Cytarabine
Showing 1 - 25 of 1,511
Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)
Not yet recruiting
- Acute Myeloid Leukemia
- (cytarabine: daunorubicin) liposome for injection
- Vyxeos
-
Tianjin, ChinaInstitute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Biospecimen Collection
- +3 more
-
Baltimore, Maryland
- +2 more
Jan 19, 2023
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
Acute Myeloid Leukemia, Core-Binding Factor Trial in Shanghai (Fludarabine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Core-Binding Factor
- Fludarabine
- Cytarabine
-
Shanghai, Shanghai, ChinaXianmin Song
May 5, 2022
Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)
Not yet recruiting
- Autologous Stem Cell Transplantation
- Conditioning
- modified BEAM
- BEAM
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- idarubicin
- Cytarabine
- (no location specified)
Sep 18, 2023
Langerhans Cell Histiocytosis Trial in Shanghai (Prednisone+Cytarabine+vincristine,
Recruiting
- Langerhans Cell Histiocytosis
-
Shanghai, ChinaShanghai Children's Medical Center
Jul 23, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +6 more
- (no location specified)
Nov 15, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk
Recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Gemtuzumab Ozogamicin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Selinexor
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,
Not yet recruiting
- Relapsed Acute Myeloid Leukemia
- +2 more
- Venetoclax, Decitabine, Azacytidine, Cytarabine
- (no location specified)
May 4, 2022
Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)
Recruiting
- Acute Lymphoblastic Leukemia
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Oct 12, 2022
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- Azacitidine
- +6 more
- (no location specified)
Nov 8, 2022
Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)
Recruiting
- Leukemia
- Cladribine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 23, 2022
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)
Recruiting
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- Cytarabine
-
Bologna, Italy
- +4 more
Jan 31, 2023
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Bisantrene Dihydrochloride (high dose)
- +3 more
-
Newcastle, New South Wales, AustraliaCalvary Mater
Jul 14, 2022
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)
Not yet recruiting
- Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
- (no location specified)
Feb 27, 2023
Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Cytarabine
- +3 more
- (no location specified)
Nov 25, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023